Microfluidics technology provides physiologically relevant cell-based models for high-throughput...
SelectScience,
Jeff Jensen, CEO of Fluxion Biosciences, describes how microfluidics technology fuels advances in drug discovery through…
Article Re-Educating the Immune Response To Treat Type 1 Diabetes CAR T-cell therapy is largely used to treat cancers, but here we explore how Dr. Leonardo Ferreira and his team are using CAR T-cell therapy to treat Type 1 diabetes.
Technology Networks,
“The immune system can be seen as an army that protects us from foreign invaders and pathogens, but sometimes this army can go…
盘点2022年11大实体瘤“明星靶点”，癌症患者关注的都在这！
CN-Healthcare,
对于癌症的治疗和攻克，我国的医学家们从未停止过研究创新的脚步，从最初的化疗药，再到现如今的靶向、免疫治疗，我们距离治愈癌症的目标也越来越近。而近期内最火的癌症疗法，当属于免疫疗法中的 嵌合抗原受体T细胞（CAR-T）。 与以往开发抗癌药物，包括最新的靶向药物…
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise
Biospace,
Gado/ CRISPR Therapeutics will present data at the Annual European Hematology Association (EHA) 2022 Hybrid Congress from the…